Google expands its health goals with new wellness features for Pixel phones
Google is taking a bite out of another piece of the health care pie. On…
Author: STAT
Merck’s Kenneth Frazier, biopharma’s irreplaceable voice, to step down as CEO
Kenneth Frazier is stepping down as the CEO of Merck, leaving a giant hole in…
.jpg)
STAT+: Pharmalittle: Switzerland rejects AstraZeneca Covid-19 vaccine; McKinsey to pay $573 million over its role in opioid crisis
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers
The McKinsey & Co. consulting firm has reached a $573 million settlement with 47 states…
23andMe to go public via Richard Branson’s SPAC
The genetics testing company 23andMe will enter the public markets via a special purpose acquisition…
Opinion: Truth and transparency after Covid-19: Mending the relationship between hospitals and the communities they serve
In April 2020, Víctor Santamaría was in an intensive care unit at Weill Cornell Medical…
Opinion: Mobilize family caregivers to speed the rollout of Covid-19 vaccines
Five years ago, I sat in a hospital lounge as a nurse laid out everything…
Thanks to physical distancing, masks, doctors see fewer cases of a polio-like condition in children
Many of the respiratory viruses that normally spike in the United States in the fall…
Why some hospitals have to scramble for oxygen to treat Covid-19 patients
As Covid-19 cases began spiking last month, Mara Bryant and her hospital staff had to…
With a seductive number, AstraZeneca study fueled hopes that eclipsed its data
A new paper released this week suggested that a vaccine developed by AstraZeneca and Oxford…
Apple Watches can help track Parkinson’s disease symptoms
Apple’s quest to put a smartwatch on every wrist continues with its latest health research:…
Opinion: Kids don’t need Covid-19 vaccines to return to school
The notion is out there that public school students should not return to in-person learning…
STAT+: Pharmalittle: GSK to partner with CureVac on Covid-19 vaccine; Jazz to buy GW Pharma in $7.2 billion deal
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Jazz Pharmaceuticals said Wednesday that it is acquiring GW Pharma, adding an approved childhood epilepsy…
Opinion: Community health centers can help stamp out Covid-19
“If you are having difficulty breathing, go to an emergency room or call 911.” This…
Opinion: Debt from attending an elite medical school shouldn’t keep new doctors from working in underserved areas
A medical degree from one of America’s elite private medical schools adds prestige to a…
STAT+: Explore STAT’s database of FDA-cleared AI tools
The Food and Drug Administration has cleared scores of AI tools for use in the…
STAT+: As the FDA clears a flood of AI tools, missing data raise troubling questions on safety and fairness
Artificial intelligence is the fastest-growing frontier in medicine, but it is also among the most…
GSK joins forces with CureVac to manufacture its Covid-19 vaccine — and to develop another
Vaccine production giant GlaxoSmithKline announced Wednesday that it would partner with German biotech CureVac to…
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
In an ideal world, a pandemic vaccine could be delivered in a single shot, so…
STAT+: STAT+ Conversations: A conversation on racial health disparities, Covid-19, and vaccine distribution
A livestream of the conversation will be embedded below at 1 p.m. ET. Every week,…
STAT+: Pharmalittle: Russia’s Covid-19 vaccine appears effective; BioCryst stock is pursued by Reddit investors
Rise and shine, everyone, another busy day is on the way. Once again, however, events…
Global trends in lung cancer show continuing disparities
With over 2 million new cases globally in 2018, lung cancer remains the most prevalent…
Verily spinout Onduo expands virtual care to Spanish speakers
The virtual care company Onduo is widening its reach: On Tuesday, the Alphabet-owned company announced…
STAT+: Who will Vertex buy? How much will it spend? Deal questions dominate its earnings call
Who (or what) is Vertex Pharmaceuticals going to buy? The question — asked many different…
Opinion: If 2021 is to be the year of U.S. drug price controls, how should biopharma companies respond?
As the Biden administration assumes leadership in Washington and former President Donald Trump’s most-favored nation…
Opinion: HHS’s ‘sunset rule’ will save money and lives
There has been a lot of hand-wringing lately over a new regulation from the Department…
A Baltimore pastor, preaching about vaccines to the Black community, emphasizes personal agency
Terris King is intimately familiar with the Black community’s skepticism about Covid-19 vaccines. The Baltimore…
STAT+: Could training AI to learn from patients give doctors a better understanding of the causes of pain?
For years, AI researchers have focused their energy on developing algorithms capable of sharpening or…
Large majority of doctors hold misconceptions about people with disabilities, survey finds
A new survey of U.S. doctors finds that more than 80% believe people with a…
STAT+: Pharmacy benefit managers take heavy criticism from a new source: local officials
In what is being described as an unusual move, a Pennsylvania county is openly blaming…
STAT+: Amid a crush of Covid-19 research, scientists hone an AI tool to rapidly screen studies
Long before the pace of scientific publishing about Covid-19 broke land speed records, researchers were…
STAT+: Pharmalittle: AstraZeneca to boost Covid-19 vaccine supplies to EU; what comes next for Biogen’s Alzheimer’s drug?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Disadvantage indices can help achieve equitable vaccine allocation
Policymakers have wrestled for months with how to fairly prioritize populations for Covid-19 vaccines. But…
Opinion: The bystander effect, Covid-19 vaccine edition
What do Covid-19 vaccination and the stabbing death of a woman outside of her New…
STAT+: The FDA delayed its decision on Biogen’s Alzheimer’s drug. Now what?
The Food and Drug Administration’s decision to take three extra months to review Biogen’s controversial…
Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science
WASHINGTON — Joe Biden’s presence at meetings of the Obama administration’s scientific advisory council sometimes…
STAT+: Biden administration pumps brakes on signature Trump drug pricing proposal
WASHINGTON — The Biden administration has agreed to delay for a year the implementation of…
A viral mystery: Can one infection prevent another?
In September 2009, the H1N1 swine flu had arrived in Portugal, Spain, and the UK,…
Trump officials actively lobbied to deny states money for vaccine rollout last fall
WASHINGTON — Top Trump officials actively lobbied Congress to deny state governments any extra funding…
Additional Covid-19 vaccines bring choices — and complications — to the rollout
It’s always good for consumers to have options, right? And indeed, the United States should…
STAT+: Pharmalittle: J&J and Novavax vaccines are effective to varying degrees; FDA delays decision on Biogen Alzheimer’s drug
And so, another working week will soon draw to a close. Not a moment too…
J&J one-dose Covid vaccine is 66% effective, a weapon but not a knockout punch
Johnson & Johnson said Friday that its single-dose Covid-19 vaccine reduced rates of moderate and…
STAT+: FDA delays approval decision for Biogen’s Alzheimer’s treatment
The Food and Drug Administration is delaying its decision on Biogen’s closely watched Alzheimer’s drug…
Opinion: Decentralized clinical trials: Collaboration is needed to drive their adoption and impact
Despite groundbreaking advances in basic and clinical science and technology, clinical trial methods have not…
Science communication in the Covid-19 era is a brave new world, for better and worse
Before 2020, the biggest debates in science communication were often about balancing hope and hype…
Pediatricians pivot to vaccines on the go as immunization rates drop during the pandemic
At the beginning of the Covid-19 pandemic, Eileen Costello, the chief of ambulatory pediatrics at…
For states, tracking Covid-19 vaccination data poses a huge challenge
After a long day of doling out Covid-19 vaccines, workers in Utah County toil late…
Listen: J&J’s imminent vaccine data, CRISPR’s confusing boom, and navigating scientific misinformation
When are we getting more Covid-19 vaccine data? Is CRISPR having a dot-com moment? And…
Novavax says its Covid-19 vaccine is 90% effective, but far less so against one variant
A Covid-19 vaccine from Novavax proved nearly 90% effective in preliminary results from a key…